Public-registry site landscape for NCT02481674, a Huntington's Disease study sponsored by Vaccinex Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02481674 (registry record) |
| Sponsor | Vaccinex Inc. |
| Condition(s) | Huntington's Disease |
| Phase | PHASE2 |
| Listed sites | 32 |
| Site countries | United States, Canada |
Eichor generates a preliminary site-risk snapshot for NCT02481674 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →